Molecular Characterization of Multiple Myeloma Ethnic Disparity

Funding Opportunity Number: RFA-FD-15-029 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthInformation and StatisticsCFDA Number: 93.103Eligible Applicants Others (see text field entitled "Additional Information on Eligibility" for clarification)Agency Name: HHS-FDAClosing Date: Jul 21, 2015Award Ceiling: $172,000Expected Number of Awards: 1Creation Date: May 22, 2015Funding Opportunity Description: The goal of this funding opportunity is to determine the molecular characteristics of Multiple Myeloma (MM) in patients of Black ethnicity compared to those of White ethnicity. The project will support the FDA's scientific mission of protecting and promoting the public health by initiating and facilitating research into the observed differences in Blacks and the relevance to drug approval and future clinical trial design.
Source: Grants.gov - Category: Research Tags: Health Information and Statistics Source Type: funding